Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Oncology ; (12): 378-381, 2012.
Article in Chinese | WPRIM | ID: wpr-335275

ABSTRACT

<p><b>OBJECTIVE</b>To analyze the clinical characteristics, influencing factors and outcome of recurrent patients with early stage bulky cervical carcinoma.</p><p><b>METHODS</b>Between January 1(st) 2000 and December 31(st) 2009, 76 patients with stage Ib2 and IIa2 bulky cervical carcinoma developed recurrence and (or) metastasis. The recurrence time, recurrence location, recurrence-related factors, treatment and survival were analyzed.</p><p><b>RESULTS</b>The median follow up was 44 months (9-137 months). The overall recurrence and (or) metastasis rate was 22.6%. The 1-, 1-2, 3-5 and 5-year recurrence and (or) metastasis rates were 38.2%, 27.6%, 30.3% and 3.9%, respectively. The 5-year survival rate of local recurrence was 34.5%, that of distant metastasis was 23.6%, and that of distant metastasis with synchronous pelvic recurrence was 11.1%, (P = 0.555). The 5-year survival rate of patients who received surgery plus chemotherapy, radiation plus chemotherapy and chemotherapy alone after recurrence and (or) metastasis were 53.3%, 30.7% and 24.6%, respectively (P = 0.686). Univariate analysis demonstrated that tumor recurrence and (or) metastasis in patients of the stage Ib2 and IIa2 bulky cervical carcinoma were influenced by the disease stage, pelvic lymph node metastasis, deep cervical stromal invasion, lymphovascular tumor thrombus and pathological types. Multivariate regression analysis demonstrated that pelvic lymph node metastasis, lymphovascular tumor thrombus and pathological types were the key factors affecting the recurrence and (or) metastases of the stage Ib2 and IIa2 bulky cervical carcinoma. Subgroup analysis showed that pelvic lymph node metastasis and stage were the main factors affecting the local recurrence in those patients, and the pathological type, vascular tumor thrombus and pelvic lymph node metastasis were the main factors affecting the distant metastasis.</p><p><b>CONCLUSIONS</b>Recurrence and(or) metastasis of early stage bulky cervical cancer are mostly happened within 2 years post operation. Patients with pelvic lymph node metastasis have high probability to develop local recurrence and distant metastasis. Patients with non-squamous cell carcinoma and lymphovascular tumor thrombus are more likely to develop distant metastasis. Neoadjuvant chemotherapy does not decrease local recurrence and distant metastasis in patients with stage Ib2 and IIa2 bulky cervical carcinoma. Individualized treatment is advised for recurrent patients.</p>


Subject(s)
Adenocarcinoma , Pathology , General Surgery , Therapeutics , Carcinoma, Squamous Cell , Pathology , General Surgery , Therapeutics , Chemotherapy, Adjuvant , Female , Follow-Up Studies , Humans , Hysterectomy , Lung Neoplasms , Drug Therapy , Lymph Node Excision , Lymph Nodes , Pathology , Lymphatic Metastasis , Multivariate Analysis , Neoadjuvant Therapy , Neoplasm Invasiveness , Neoplasm Recurrence, Local , General Surgery , Therapeutics , Neoplasm Staging , Pelvis , Radiotherapy, Adjuvant , Survival Rate , Tumor Burden , Uterine Cervical Neoplasms , Pathology , General Surgery , Therapeutics
2.
Chinese Journal of Oncology ; (12): 286-289, 2010.
Article in Chinese | WPRIM | ID: wpr-260416

ABSTRACT

<p><b>OBJECTIVE</b>To analyze the survival status and prognostic factors of patients with liver metastases from colorectal cancer.</p><p><b>METHODS</b>The survival rate and prognostic factors of 112 patients with liver metastases from colorectal cancer, who had complete follow-up data, were retrospectively assessed by Kaplan-Meier analysis and multivariate regression analysis.</p><p><b>RESULTS</b>The median survival time of the 112 patients was 18.25 months. The 1-, 2-, 3- and 5-year overall survival rates were 60.8%, 35.0%, 20.3% and 4.8%, respectively. Univariate analysis demonstrated that gender, age, primary tumor site, chemotherapy and pathological types had no significant correlation with the overall survival. But the treatment of primary tumor, time of liver metastasis, gross type of tumor, resection of liver metastases and clinical stage status were all independently related with the prognosis of patients. Multivariate regression analysis showed that resection of liver metastases, gross type of tumor and clinical stage were key factors affecting the prognosis of patients with liver metastases from colorectal cancer.</p><p><b>CONCLUSION</b>Patients with advanced stage, infiltrative gross type of colorectal cancer should be followed-up closely so that liver metastases from the cancer can be diagnosed and treated early. Resection of both the primary tumor and liver metastasis may improve survival of the patients.</p>


Subject(s)
Adenocarcinoma , Pathology , General Surgery , Adenocarcinoma, Mucinous , Pathology , General Surgery , Adult , Aged , Aged, 80 and over , Colonic Neoplasms , Pathology , General Surgery , Female , Follow-Up Studies , Hepatectomy , Humans , Liver Neoplasms , Drug Therapy , General Surgery , Male , Middle Aged , Neoplasm Staging , Proportional Hazards Models , Rectal Neoplasms , Pathology , General Surgery , Retrospective Studies , Survival Rate , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL